Correlation Between Varex Imaging and Collplant Biotechnologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Varex Imaging and Collplant Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Varex Imaging and Collplant Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Varex Imaging Corp and Collplant Biotechnologies, you can compare the effects of market volatilities on Varex Imaging and Collplant Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Varex Imaging with a short position of Collplant Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Varex Imaging and Collplant Biotechnologies.

Diversification Opportunities for Varex Imaging and Collplant Biotechnologies

0.77
  Correlation Coefficient

Poor diversification

The 3 months correlation between Varex and Collplant is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Varex Imaging Corp and Collplant Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Collplant Biotechnologies and Varex Imaging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Varex Imaging Corp are associated (or correlated) with Collplant Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Collplant Biotechnologies has no effect on the direction of Varex Imaging i.e., Varex Imaging and Collplant Biotechnologies go up and down completely randomly.

Pair Corralation between Varex Imaging and Collplant Biotechnologies

Given the investment horizon of 90 days Varex Imaging Corp is expected to generate 0.93 times more return on investment than Collplant Biotechnologies. However, Varex Imaging Corp is 1.08 times less risky than Collplant Biotechnologies. It trades about -0.09 of its potential returns per unit of risk. Collplant Biotechnologies is currently generating about -0.14 per unit of risk. If you would invest  1,442  in Varex Imaging Corp on December 30, 2024 and sell it today you would lose (290.00) from holding Varex Imaging Corp or give up 20.11% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Varex Imaging Corp  vs.  Collplant Biotechnologies

 Performance 
       Timeline  
Varex Imaging Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Varex Imaging Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Collplant Biotechnologies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Collplant Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Varex Imaging and Collplant Biotechnologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Varex Imaging and Collplant Biotechnologies

The main advantage of trading using opposite Varex Imaging and Collplant Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Varex Imaging position performs unexpectedly, Collplant Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collplant Biotechnologies will offset losses from the drop in Collplant Biotechnologies' long position.
The idea behind Varex Imaging Corp and Collplant Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance